Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 16 (MTND4P16) is a nuclear pseudogene related to the mitochondrial gene MT-ND4, which encodes a core subunit of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial electron transport chain[4]. Unlike the mitochondrial MT-ND4 gene, MTND4P16 does not encode a functional protein and thus has no known biological role. Pseudogene sequences are typically non-functional remnants of genes that may arise through duplication or the integration of mitochondrial DNA fragments into the nuclear genome. The existence of nuclear-embedded mitochondrial gene pseudogenes, including those of MT-ND4, has been documented, but these sequences do not encode proteins, do not contribute to cellular metabolism, and are not considered therapeutic targets[4].\n\nExplanatory notes:\n- MTND4P16 is a pseudogene, not an active gene or protein. It is the nuclear remnant of an originally mitochondrial gene and does not encode a functional protein product[4].\n- Pseudogenes like MTND4P16 may be amplified in DNA studies but do not participate in mitochondrial respiration or energy production[4].\n- Only the authentic MT-ND4 mitochondrial gene (not the pseudogene) encodes a subunit essential for mitochondrial Complex I function, and only that gene is associated with mitochondrial disease mechanisms[1][3][5].\n- As a result, MTND4P16 is not a valid therapeutic target and is not associated with any known direct drug interactions, biological functions, or disease roles.\nIf you are seeking information about the functional mitochondrial gene, refer to MT-ND4 (NADH:ubiquinone oxidoreductase core subunit 4) instead[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 16 (MTND4P16).